resTORbio initiates phase III program of RTB-101 in clinically symptomatic respiratory illness May 10, 2019
First patient treated in phase I study MCLA-145 for the treatment of advanced solid tumors May 10, 2019
Phase II results on ribaxamase to prevent C. difficile infection in beta-lactam-treated patients May 10, 2019
Imidazopyridines targeting methionyl-tRNA synthetase for the treatment of Cryptosporidium infection May 10, 2019
Gilead and Goldfinch Bio enter strategic collaboration to develop novel therapies for kidney disease May 10, 2019
RSS